Literature DB >> 20501756

Spatial patterns of localized-stage prostate cancer incidence among white and black men in the southeastern United States, 1999-2001.

Sean F Altekruse1, Lan Huang, James E Cucinelli, Timothy S McNeel, Kristen M Wells, M Norman Oliver.   

Abstract

BACKGROUND: In the United States, prostate cancer incidence is higher among black than among white males, with a higher proportion of blacks diagnosed with advanced-stage cancer.
METHODS: Prostate cancer incidence (1999-2001) and census tract data were obtained for 66,468 cases in four states that account for 20% of U.S. blacks: Georgia, Florida, Alabama, and Tennessee. Spatial clusters of localized-stage prostate cancer incidence were detected by spatial scan. Clusters were examined by relative risk, population density, and socioeconomic and racial attributes.
RESULTS: Overall prostate cancer incidence rates were higher in black than in white men, and a lower proportion of black cases were diagnosed with localized-stage cancer. Strong associations were seen between urban residence and high relative risk of localized-stage cancer. The highest relative risks generally occurred in clusters with a lower percent black population than the national average. Conversely, of eight nonurban clusters with significantly elevated relative risk of localized-disease, seven had a higher proportion of blacks than the national average. Furthermore, positive correlations between percent black population and relative risk of localized-stage cancer were seen in Alabama and Georgia.
CONCLUSION: Association between urban residence and high relative risk of localized-stage disease (favorable prognosis) persisted after spatial clusters were stratified by percent black population. Unexpectedly, seven of eight nonurban clusters with high relative risk of localized-stage disease had a higher percentage of blacks than the U.S. population. IMPACT: Although evidence of racial disparity in prostate cancer was found, there were some encouraging findings. Studies of community-level factors that might contribute to these findings are recommended. Copyright 2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 20501756      PMCID: PMC2883026          DOI: 10.1158/1055-9965.EPI-09-1310

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  13 in total

1.  An elliptic spatial scan statistic.

Authors:  Martin Kulldorff; Lan Huang; Linda Pickle; Luiz Duczmal
Journal:  Stat Med       Date:  2006-11-30       Impact factor: 2.373

2.  Geographically based investigation of prostate cancer mortality in four U.S. Northern Plain states.

Authors:  Jennifer A Rusiecki; Martin Kulldorff; John R Nuckols; Changhong Song; Mary H Ward
Journal:  Am J Prev Med       Date:  2006-02       Impact factor: 5.043

3.  Spatial analysis of prostate cancer incidence and race in Virginia, 1990-1999.

Authors:  M Norman Oliver; Eric Smith; Mir Siadaty; Fern R Hauck; Linda W Pickle
Journal:  Am J Prev Med       Date:  2006-02       Impact factor: 5.043

4.  Relation between population density and cancer incidence, Illinois, 1986-1990.

Authors:  H L Howe; J E Keller; M Lehnherr
Journal:  Am J Epidemiol       Date:  1993-07-01       Impact factor: 4.897

5.  Race, socioeconomic status and stage at diagnosis for five common malignancies.

Authors:  Kendra L Schwartz; Heather Crossley-May; Fawn D Vigneau; Karl Brown; Mousumi Banerjee
Journal:  Cancer Causes Control       Date:  2003-10       Impact factor: 2.506

6.  The impact of socioeconomic status on survival after cancer in the United States : findings from the National Program of Cancer Registries Patterns of Care Study.

Authors:  Tim E Byers; Holly J Wolf; Katrina R Bauer; Susan Bolick-Aldrich; Vivien W Chen; Jack L Finch; John P Fulton; Maria J Schymura; Tiefu Shen; Scott Van Heest; Xiang Yin
Journal:  Cancer       Date:  2008-08-01       Impact factor: 6.860

7.  Prostate cancer severity among low income, uninsured men.

Authors:  David C Miller; Mark S Litwin; Jonathan Bergman; Sevan Stepanian; Sarah E Connor; Lorna Kwan; William J Aronson
Journal:  J Urol       Date:  2008-12-18       Impact factor: 7.450

8.  Rural reversal? Rural-urban disparities in late-stage cancer risk in Illinois.

Authors:  Sara McLafferty; Fahui Wang
Journal:  Cancer       Date:  2009-06-15       Impact factor: 6.860

9.  Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.

Authors:  Limin X Clegg; Marsha E Reichman; Barry A Miller; Benjamin F Hankey; Gopal K Singh; Yi Dan Lin; Marc T Goodman; Charles F Lynch; Stephen M Schwartz; Vivien W Chen; Leslie Bernstein; Scarlett L Gomez; John J Graff; Charles C Lin; Norman J Johnson; Brenda K Edwards
Journal:  Cancer Causes Control       Date:  2008-11-12       Impact factor: 2.506

10.  Spatial trends of breast and prostate cancers in the United States between 2000 and 2005.

Authors:  Rakesh Mandal; Sophie St-Hilaire; John G Kie; DeWayne Derryberry
Journal:  Int J Health Geogr       Date:  2009-09-29       Impact factor: 3.918

View more
  14 in total

1.  Rural-Urban Differences in Cancer Incidence and Trends in the United States.

Authors:  Whitney E Zahnd; Aimee S James; Wiley D Jenkins; Sonya R Izadi; Amanda J Fogleman; David E Steward; Graham A Colditz; Laurent Brard
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-07-27       Impact factor: 4.254

2.  Life-Threatening Disparities: The Treatment of Black and White Cancer Patients.

Authors:  Louis A Penner; Susan Eggly; Jennifer J Griggs; Willie Underwood; Heather Orom; Terrance L Albrecht
Journal:  J Soc Issues       Date:  2012-06-25

3.  Associations between arachidonic acid metabolism gene polymorphisms and prostate cancer risk.

Authors:  E Susan Amirian; Michael M Ittmann; Michael E Scheurer
Journal:  Prostate       Date:  2011-02-09       Impact factor: 4.104

4.  Bruton's tyrosine kinase is a potential therapeutic target in prostate cancer.

Authors:  Leila Kokabee; Xianhui Wang; Christopher J Sevinsky; Wei Lin Winnie Wang; Lindsay Cheu; Sridar V Chittur; Morteza Karimipoor; Martin Tenniswood; Douglas S Conklin
Journal:  Cancer Biol Ther       Date:  2015-09-18       Impact factor: 4.742

5.  Pathogenic Germline DNA Repair Gene and HOXB13 Mutations in Men With Metastatic Prostate Cancer.

Authors:  Julie L Boyle; Andrew W Hahn; Ashley L Kapron; Wendy Kohlmann; Samantha E Greenberg; Timothy J Parnell; Craig C Teerlink; Benjamin L Maughan; Bing-Jian Feng; Lisa Cannon-Albright; Neeraj Agarwal; Kathleen A Cooney
Journal:  JCO Precis Oncol       Date:  2020-03-04

6.  Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

Authors:  Fredrick R Schumacher; Ali Amin Al Olama; Sonja I Berndt; Sara Benlloch; Mahbubl Ahmed; Edward J Saunders; Tokhir Dadaev; Daniel Leongamornlert; Ezequiel Anokian; Clara Cieza-Borrella; Chee Goh; Mark N Brook; Xin Sheng; Laura Fachal; Joe Dennis; Jonathan Tyrer; Kenneth Muir; Artitaya Lophatananon; Victoria L Stevens; Susan M Gapstur; Brian D Carter; Catherine M Tangen; Phyllis J Goodman; Ian M Thompson; Jyotsna Batra; Suzanne Chambers; Leire Moya; Judith Clements; Lisa Horvath; Wayne Tilley; Gail P Risbridger; Henrik Gronberg; Markus Aly; Tobias Nordström; Paul Pharoah; Nora Pashayan; Johanna Schleutker; Teuvo L J Tammela; Csilla Sipeky; Anssi Auvinen; Demetrius Albanes; Stephanie Weinstein; Alicja Wolk; Niclas Håkansson; Catharine M L West; Alison M Dunning; Neil Burnet; Lorelei A Mucci; Edward Giovannucci; Gerald L Andriole; Olivier Cussenot; Géraldine Cancel-Tassin; Stella Koutros; Laura E Beane Freeman; Karina Dalsgaard Sorensen; Torben Falck Orntoft; Michael Borre; Lovise Maehle; Eli Marie Grindedal; David E Neal; Jenny L Donovan; Freddie C Hamdy; Richard M Martin; Ruth C Travis; Tim J Key; Robert J Hamilton; Neil E Fleshner; Antonio Finelli; Sue Ann Ingles; Mariana C Stern; Barry S Rosenstein; Sarah L Kerns; Harry Ostrer; Yong-Jie Lu; Hong-Wei Zhang; Ninghan Feng; Xueying Mao; Xin Guo; Guomin Wang; Zan Sun; Graham G Giles; Melissa C Southey; Robert J MacInnis; Liesel M FitzGerald; Adam S Kibel; Bettina F Drake; Ana Vega; Antonio Gómez-Caamaño; Robert Szulkin; Martin Eklund; Manolis Kogevinas; Javier Llorca; Gemma Castaño-Vinyals; Kathryn L Penney; Meir Stampfer; Jong Y Park; Thomas A Sellers; Hui-Yi Lin; Janet L Stanford; Cezary Cybulski; Dominika Wokolorczyk; Jan Lubinski; Elaine A Ostrander; Milan S Geybels; Børge G Nordestgaard; Sune F Nielsen; Maren Weischer; Rasmus Bisbjerg; Martin Andreas Røder; Peter Iversen; Hermann Brenner; Katarina Cuk; Bernd Holleczek; Christiane Maier; Manuel Luedeke; Thomas Schnoeller; Jeri Kim; Christopher J Logothetis; Esther M John; Manuel R Teixeira; Paula Paulo; Marta Cardoso; Susan L Neuhausen; Linda Steele; Yuan Chun Ding; Kim De Ruyck; Gert De Meerleer; Piet Ost; Azad Razack; Jasmine Lim; Soo-Hwang Teo; Daniel W Lin; Lisa F Newcomb; Davor Lessel; Marija Gamulin; Tomislav Kulis; Radka Kaneva; Nawaid Usmani; Sandeep Singhal; Chavdar Slavov; Vanio Mitev; Matthew Parliament; Frank Claessens; Steven Joniau; Thomas Van den Broeck; Samantha Larkin; Paul A Townsend; Claire Aukim-Hastie; Manuela Gago-Dominguez; Jose Esteban Castelao; Maria Elena Martinez; Monique J Roobol; Guido Jenster; Ron H N van Schaik; Florence Menegaux; Thérèse Truong; Yves Akoli Koudou; Jianfeng Xu; Kay-Tee Khaw; Lisa Cannon-Albright; Hardev Pandha; Agnieszka Michael; Stephen N Thibodeau; Shannon K McDonnell; Daniel J Schaid; Sara Lindstrom; Constance Turman; Jing Ma; David J Hunter; Elio Riboli; Afshan Siddiq; Federico Canzian; Laurence N Kolonel; Loic Le Marchand; Robert N Hoover; Mitchell J Machiela; Zuxi Cui; Peter Kraft; Christopher I Amos; David V Conti; Douglas F Easton; Fredrik Wiklund; Stephen J Chanock; Brian E Henderson; Zsofia Kote-Jarai; Christopher A Haiman; Rosalind A Eeles
Journal:  Nat Genet       Date:  2018-06-11       Impact factor: 38.330

Review 7.  Vitamin D, intermediary metabolism and prostate cancer tumor progression.

Authors:  Wei-Lin W Wang; Martin Tenniswood
Journal:  Front Physiol       Date:  2014-05-15       Impact factor: 4.566

8.  Do evolutionary life-history trade-offs influence prostate cancer risk? a review of population variation in testosterone levels and prostate cancer disparities.

Authors:  Louis Calistro Alvarado
Journal:  Evol Appl       Date:  2012-12-11       Impact factor: 5.183

9.  Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.

Authors:  Adriana C Vidal; Cocoa Tucker; Joellen M Schildkraut; Ricardo M Richardson; Megan McPhail; Stephen J Freedland; Cathrine Hoyo; Delores J Grant
Journal:  BMC Cancer       Date:  2013-11-22       Impact factor: 4.430

10.  Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma.

Authors:  Christoph-A von Klot; Mario W Kramer; Inga Peters; Joerg Hennenlotter; Mahmoud Abbas; Ralph Scherer; Thomas Rw Herrmann; Arnulf Stenzl; Markus A Kuczyk; Juergen Serth; Axel S Merseburger
Journal:  BMC Clin Pathol       Date:  2014-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.